VWF anticorps (AA 1304-1452)
-
- Antigène Voir toutes VWF Anticorps
- VWF (Von Willebrand Factor (VWF))
-
Épitope
- AA 1304-1452
-
Reactivité
- Rat, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp VWF est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Fonction
- Rabbit IgG polyclonal antibody for von Willebrand factor(VWF) detection. Tested with WB, IHC-P in Mouse,Rat.
- Réactivité croisée (Details)
- No cross reactivity with other proteins.
- Attributs du produit
-
Rabbit IgG polyclonal antibody for von Willebrand factor(VWF) detection. Tested with WB, IHC-P in Mouse,Rat.
Gene Name: von Willebrand factor
Protein Name: von Willebrand factor - Purification
- Immunogen affinity purified.
- Immunogène
- E.coli-derived mouse VWF recombinant protein (Position: M1304-E1452).
- Isotype
- IgG
- Top Product
- Discover our top product VWF Anticorps primaire
-
-
- Indications d'application
-
WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Mouse, Rat, The detection limit for VWF is approximately 0.25 ng/lane under reducing conditions.
IHC-P: Concentration: 0.5-1 μg/mL, Tested Species: Mouse, Rat, Epitope Retrieval by Heat: Boiling the paraffin sections in 10 mM citrate buffer, pH 6.0, for 20 mins is required for the staining of formalin/paraffin sections.
Notes: Tested Species: Species with positive results. Other applications have not been tested. Optimal dilutions should be determined by end users. - Commentaires
-
Antibody can be supported by chemiluminescence kit ABIN921124 in WB, supported by ABIN921231 in IHC(P).
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
- Concentration
- 500 μg/mL
- Buffer
- Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
-
At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
-
-
Preparation of a nano- and micro-fibrous decellularized scaffold seeded with autologous mesenchymal stem cells for inguinal hernia repair." dans: International journal of nanomedicine, Vol. 12, pp. 1441-1452, (2017) (PubMed).
: "Expression and correlation analysis of RegIV and vascular endothelial growth factors (VEGF-A and VEGF-C) in metastatic spinal tumors." dans: Oncology letters, Vol. 13, Issue 5, pp. 3517-3521, (2017) (PubMed).
: "Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-β1-CTGF-VEGF functional module in rheumatoid arthritis." dans: Oncotarget, Vol. 8, Issue 43, pp. 73529-73546, (2017) (PubMed).
: "Calcium signaling is implicated in the diffuse axonal injury of brain stem." dans: International journal of clinical and experimental pathology, Vol. 8, Issue 5, pp. 4388-97, (2016) (PubMed).
: "Effect of Hyperbaric Oxygen on the Growth of Intracranial Glioma in Rats." dans: Chinese medical journal, Vol. 128, Issue 23, pp. 3197-203, (2016) (PubMed).
: "Resveratrol Protects against TNF-α-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK." dans: PLoS ONE, Vol. 11, Issue 1, pp. e0147034, (2016) (PubMed).
: "Paxillin regulates vascular endothelial growth factor A-induced in vitro angiogenesis of human umbilical vein endothelial cells." dans: Molecular medicine reports, Vol. 11, Issue 3, pp. 1784-92, (2015) (PubMed).
: "Correction: IFI6 Inhibits Apoptosis via Mitochondrial-Dependent Pathway in Dengue Virus 2 Infected Vascular Endothelial Cells." dans: PLoS ONE, Vol. 10, Issue 9, pp. e0138896, (2015) (PubMed).
: "Construction of tissue-engineered bone using a bioreactor and platelet-rich plasma." dans: Experimental and therapeutic medicine, Vol. 8, Issue 2, pp. 413-418, (2014) (PubMed).
: "Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro." dans: Experimental and therapeutic medicine, Vol. 8, Issue 2, pp. 647-651, (2014) (PubMed).
: "Effects of transforming growth factor-?2 on myocilin expression and secretion in human primary cultured trabecular meshwork cells." dans: International journal of clinical and experimental pathology, Vol. 7, Issue 8, pp. 4827-36, (2014) (PubMed).
: "Performance of a multilayered small-diameter vascular scaffold dual-loaded with VEGF and PDGF." dans: Biomaterials, Vol. 34, Issue 30, pp. 7302-13, (2013) (PubMed).
: "Pinocembrin, a major flavonoid in propolis, improves the biological functions of EPCs derived from rat bone marrow through the PI3K-eNOS-NO signaling pathway." dans: Cytotechnology, Vol. 65, Issue 4, pp. 541-51, (2013) (PubMed).
: "Vascularized bone tissue formation induced by fiber-reinforced scaffolds cultured with osteoblasts and endothelial cells." dans: BioMed research international, Vol. 2013, pp. 854917, (2013) (PubMed).
: "Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas." dans: Cytotechnology, Vol. 61, Issue 1-2, pp. 65-72, (2010) (PubMed).
: "PlexinA1 expression in gastric carcinoma and its relationship with tumor angiogenesis and proliferation." dans: World journal of gastroenterology, Vol. 13, Issue 48, pp. 6558-61, (2007) (PubMed).
: "Histological type of oncogenity and expression of cell cycle genes in tumor cells from human mesenchymal stem cells." dans: Oncology reports, Vol. 16, Issue 5, pp. 1021-8, (2006) (PubMed).
: "
-
Preparation of a nano- and micro-fibrous decellularized scaffold seeded with autologous mesenchymal stem cells for inguinal hernia repair." dans: International journal of nanomedicine, Vol. 12, pp. 1441-1452, (2017) (PubMed).
-
- Antigène
- VWF (Von Willebrand Factor (VWF))
- Autre désignation
- VWF (VWF Produits)
- Synonymes
- anticorps VWF, anticorps si:ch1073-474e24.1, anticorps F8VWF, anticorps VWD, anticorps 6820430P06Rik, anticorps AI551257, anticorps B130011O06Rik, anticorps C630030D09, anticorps von Willebrand factor, anticorps Von Willebrand factor, anticorps VWF, anticorps vwf, anticorps Vwf
- Sujet
-
Von Willebrand factor (VWF) is a blood glycoprotein involved in hemostasis. It is mapped to 12p13.31. The VWF gene encodes von Willebrand factor (VWF), a large multimeric glycoprotein that plays a central role in the blood coagulation system, serving both as a major mediator of platelet-vessel wall interaction and platelet adhesion, and as a carrier for coagulation factor VIII. VWF released from endothelial cell Weibel-Palade bodies bound particularly avidly to the extracellular matrix. VWF deficiency or dysfunction (von Willebrand disease) leads to a bleeding tendency, which is most apparent in tissues having high blood flow shear in narrow vessels.
Synonyms: Coagulation factor VIII antibody|Coagulation factor VIII VWF antibody|F8VWF antibody|Factor VIII related antigen antibody|von Willebrand antigen 2 antibody|Von Willebrand antigen II antibody|Von Willebrand disease antibody|VWD antibody|VWF antibody|VWF_HUMAN antibody - ID gène
- 22371
-